Biomarkers in Gastrointestinal Cancer: Evidence-Based Treatment in the Precision Medicine Era

Download All
On-demand webcast and downloadable slideset covering the latest on managing gastrointestinal malignancies based on biomarker assessments.
John L. Marshall, MD
Program Director
John L. Marshall, MD
Manish A. Shah, MD
Rachna Shroff, MD

On-Demand Webcast

Watch this on-demand webcast from a live satellite symposium covering the latest in biomarker testing and the use of targeted therapeutics in gastrointestinal cancers.

John L. Marshall, MD
Program Director
Manish A. Shah, MD Rachna Shroff, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: February 11, 2022 Expired: February 10, 2023

Downloadable Slidesets

Download this slideset for expert perspectives on best practices in testing for tumor-agnostic and CRC-specific biomarkers—including MSI/MMR, TMB, NTRK fusions, BRAF/RAS mutations, and HER2 amplifications—and use of related targeted therapeutics. 

John L. Marshall, MD Released: January 21, 2022

Download this slideset to learn how experts approach biomarker testing and leverage testing results to inform treatment strategies for patients with gastroesophageal cancers.

Manish A. Shah, MD Released: January 21, 2022

Download this slideset to learn how experts approach biomarker testing and leverage testing results to inform treatment strategies for patients with pancreatic and biliary tract cancers.

Rachna Shroff, MD Released: January 21, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bayer HealthCare Pharmaceuticals Inc.
Merck Sharp & Dohme Corp.
Turning Point Therapeutics, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings